BioSpace News Archive

CPhI Worldwide pharma survey shows improving outlook for pharma economies globally, with China and India showing the fastest improvement

More than 120 attendees gathered from the 17th to 18th October in Hannover for the European Business Development Conference (EBDC), the yearly biotech partnering event of the German biotechnology industry association BIO Deutschland.

CRO serves as the Statistical and Clinical Coordinating Center for NIH-sponsored study

Sudden unexpected death in epilepsy (SUDEP) occurs in approximately 1/1000 people with epilepsy and is poorly understood

It may not have always felt like it, but biotech has been in a bull market mode over the past two-and-a-half years, ever since the iShares Biotechnology Index (IBB) bottomed out at $80.01 on February 9, 2016.

There are many reasons employees elect to remain at a given job: good salary and benefits, a strong sense of mission or duty, convenience, and so on. There are also many reasons that employees decide to leave a job – and one very common reason is management.

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announces that data from a phase I study assessing the safety and tolerability of its lead drug candidate SNF472 in haemodialysis patients has been published in the British Journal of Clinical Pharmacology.

D3A will support important research projects with potential to create meaningful new medicines for dementia

Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options

Shares of Ann Arbor, Mich.-based Esperion Therapeutics are up more than 7 percent in premarket trading after the company announced on Sunday that planned to seek regulatory approval for its cholesterol-lowering therapy that hit the mark in a Phase III trial.